NEWS
Crown faces new money laundering scandal reveal in inquiry
MELBOURNE: Crown Resorts faces a fresh money laundering scandal stemming from its illegal ... read more
Mesoblast set to line up another FDA chat
MELBOURNE: Shares in stem cell treatments developer Mesoblast opened 3 per cent higher ... read more
Crescent seeks buyer for clinical trials biz Nucleus
MELBOURNE: Australian private equity firm Crescent Capital Partners has put its clinical research ... read more
